PortalPublikationenSARS-CoV-2-related and Covid-19 vaccine-induced thromboembol...

SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review

Standard

SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review. / Afshar, Zeinab Mohseni; Barary, Mohammad; Babazadeh, Arefeh; Hosseinzadeh, Rezvan; Alijanpour, Amirmasoud; Miri, Seyed Rouhollah; Sio, Terence T; Sullman, Mark J M; Carson-Chahhoud, Kristin; Langer, Florian; Ebrahimpour, Soheil.

in: REV MED VIROL, Jahrgang 32, Nr. 4, e2327, 07.2022.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Afshar, ZM, Barary, M, Babazadeh, A, Hosseinzadeh, R, Alijanpour, A, Miri, SR, Sio, TT, Sullman, MJM, Carson-Chahhoud, K, Langer, F & Ebrahimpour, S 2022, 'SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review', REV MED VIROL, Jg. 32, Nr. 4, e2327. https://doi.org/10.1002/rmv.2327

APA

Afshar, Z. M., Barary, M., Babazadeh, A., Hosseinzadeh, R., Alijanpour, A., Miri, S. R., Sio, T. T., Sullman, M. J. M., Carson-Chahhoud, K., Langer, F., & Ebrahimpour, S. (2022). SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review. REV MED VIROL, 32(4), [e2327]. https://doi.org/10.1002/rmv.2327

Vancouver

Afshar ZM, Barary M, Babazadeh A, Hosseinzadeh R, Alijanpour A, Miri SR et al. SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review. REV MED VIROL. 2022 Jul;32(4). e2327. https://doi.org/10.1002/rmv.2327

Bibtex

@article{b5427f250ea94f55a110ab0c397cd16d,
title = "SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review",
abstract = "Since the start of the pandemic, thrombotic events have been a well-known and severe complication associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nevertheless, the initiation of vaccination programs brought another rare yet highly fatal thrombotic event, vaccine-induced immune thrombotic thrombocytopaenia, which has caused extensive debate regarding the safety of vaccines. This review defines the thromboembolic events following infection and vaccination, identifies their risk factors, describes their pathophysiology, and discusses their management, treatment, and prevention.",
author = "Afshar, {Zeinab Mohseni} and Mohammad Barary and Arefeh Babazadeh and Rezvan Hosseinzadeh and Amirmasoud Alijanpour and Miri, {Seyed Rouhollah} and Sio, {Terence T} and Sullman, {Mark J M} and Kristin Carson-Chahhoud and Florian Langer and Soheil Ebrahimpour",
note = "{\textcopyright} 2022 John Wiley & Sons Ltd.",
year = "2022",
month = jul,
doi = "10.1002/rmv.2327",
language = "English",
volume = "32",
journal = "REV MED VIROL",
issn = "1052-9276",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review

AU - Afshar, Zeinab Mohseni

AU - Barary, Mohammad

AU - Babazadeh, Arefeh

AU - Hosseinzadeh, Rezvan

AU - Alijanpour, Amirmasoud

AU - Miri, Seyed Rouhollah

AU - Sio, Terence T

AU - Sullman, Mark J M

AU - Carson-Chahhoud, Kristin

AU - Langer, Florian

AU - Ebrahimpour, Soheil

N1 - © 2022 John Wiley & Sons Ltd.

PY - 2022/7

Y1 - 2022/7

N2 - Since the start of the pandemic, thrombotic events have been a well-known and severe complication associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nevertheless, the initiation of vaccination programs brought another rare yet highly fatal thrombotic event, vaccine-induced immune thrombotic thrombocytopaenia, which has caused extensive debate regarding the safety of vaccines. This review defines the thromboembolic events following infection and vaccination, identifies their risk factors, describes their pathophysiology, and discusses their management, treatment, and prevention.

AB - Since the start of the pandemic, thrombotic events have been a well-known and severe complication associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nevertheless, the initiation of vaccination programs brought another rare yet highly fatal thrombotic event, vaccine-induced immune thrombotic thrombocytopaenia, which has caused extensive debate regarding the safety of vaccines. This review defines the thromboembolic events following infection and vaccination, identifies their risk factors, describes their pathophysiology, and discusses their management, treatment, and prevention.

U2 - 10.1002/rmv.2327

DO - 10.1002/rmv.2327

M3 - SCORING: Review article

C2 - 35112763

VL - 32

JO - REV MED VIROL

JF - REV MED VIROL

SN - 1052-9276

IS - 4

M1 - e2327

ER -